The Venture Codex Logo

The Venture Codex

Overview

Oncology-focused biopharmaceutical company developing cancer therapies.

Total Raised

$497 M

Rounds

3

Links

Verticals

Biopharma
Biotechnology
Clinical Trials
Health Care
Medical
Pharmaceutical
...

Investment History

  1. Equity

    Jan 2024

    $320M

  2. Series C

    Nov 2017

    $107M

  3. Series B

    Sep 2016

    $70M

Team

Terry Rosen

Founder and CEO

Juan Jaen

President & Co-Founder

Nick Giafis

Vice President and Head of Medical Affairs

William Grossman

Chief Medical Officer